Abstract: A series of novel imperatorin derivatives were synthesized from commercially available xanthotoxin. The in vitro pharmacological evaluation indicated that all of the compounds possessed potent vasodilatory activity. Among them, compounds (5b), (5d) and (5e) exhibited higher vasdilatory activity (with EC 50 values of 0.68 µM, 0.59 µM and 0.49 µM, respectively) than imperatorin (EC 50 = 1.12 µM). The program Volsurf was used to predict the derivatives' ADMErelevant descriptors. The results suggested that these novel compounds had a potential interest for the development of novel and potent vasorelaxant agents.
INTRODUCTION
Hypertension is the most common reversible risk factor for cardiovascular disease and is a major risk for accelerated atherogenesis and cardiovascular morbidity [1] . Conventional therapy to treat hypertension often involves arterial vasodilation. Recently, most interest has been focused on the development of novel vasorelaxant agents to control blood pressure [2] .
Imperatorin (IMP; 9-(3-methylbut-2-enyloxy)-7H-furo[3, 2-g]chromen-7-one) is a bioactive furanocoumarin isolated from roots of Angelica dahurica and fruits of Angelica archangelica (Umbelliferae) [3] . Furanocoumarin has been reported to possess a wide range of biological activities. Imperatorin exhibits many pharmacological activities such as anti-inflammatory and anticancer effects [4] . Moreover imperatorin has been reported to show antivirus, anti-HIV, antifungal, antibacterial, antioxidant, β-secretase inhibitory and hepatoprotective activities [5] .
In our previous studies, we used vascular smooth muscle/cell membrane chromatography (VSM/CMC) combined with gas chromatography/mass spectrometry (GC/MS) method for recognition, separation and identification of active components from traditional Chinese medicines. Imperatorin was identified as the retention component from the extracts in the VSM/CMC model [6] . Imperatorin was initially tested by us in vitro as a vasorelaxant agent. We found that imperatorin could induce vasodilatation. The possible mechanisms of the vasodilatation are mainly involved with inhibiting voltage dependent calcium channel and receptormediated Ca 2+ influx and release, and might be partly due to opening calcium-activated potassium channel and competitive antagonism of 5-HT receptors [7] . Superior to traditional vasodilators such as dihydropyridine and phenylalkylamine, imperatorin possessed additional antiaggregatory activity, *Address correspondence to this author at the 54#, College of Medicine, Xi'an Jiaotong University, No. 76, Yanta Weststreet, Xi'an, Shaanxi Province, 710061, P.R. China; Tel: +86-29-82657740; Fax:+86-29-82655451; E-mail: zhj8623@mail.xjtu.edu.cn which was also very important for the treatment of cardiovascular diseases. Therefore, development of potent imperatorin derivatives would be very interesting, and may result in new leads. This would be a good strategy for vasorelaxant agents design.
However, some studies have demonstrated that the use of imperatorin is limited by its poor solubility. Poor solubility is a major problem in the biological testing of compounds, which has made formulating the compounds a challenge for in vivo studies of efficacy and pharmacokinetics [8] . This notwithstanding, imperatorin remains a good lead compound for the design of derivatives with increased activity and solubility. Incorporation of a nitrogen atom in a molecule is usually associated with the improvement of solubility. We designed and synthesized a series of novel nitrogencontaining imperatorin derivatives ( Fig. 1) to improve the solubility and drug-like properties. In this paper, we also reported the evaluation of their vasorelaxant activity in isolated rat mesenteric artery rings. Herein we used imperatorin as lead compound and modified its structure to develop novel vasorelaxant agents.
Fig. (1).
Structures of imperatorin (1) and derivatives (2).
CHEMISTRY
In this study, nine imperatorin derivatives have been designed, synthesized and tested as vasorelaxant agents in order to obtain potential antihypertensive lead compounds. All the title compounds were synthesized from commercially available xanthotoxin (Scheme 1 and Scheme 2). Synthesis of xanthotoxol (4) was achieved by the demethylation of xanthotoxin (3) . Treatment with an excess of boron tribromide afforded the desired phenol in good yields [9] . The synthesis of nitrogen-containing imperatorin derivatives (5c-5h) were performed by alkylation of the xanthotoxol (4) with chloro or bromo-substituted compounds under basic conditions, affording the desired compound in good yields [10] . Another two compounds (5a, 5b) were synthesized in the same way to research the individual contribution of the methyl and carbon-carbon double bond of imperatorin to its biological activity.
On the basis of the structure of calcium channel blocker nicardipine, we synthesized the other novel imperatorin derivative (5i). We examined whether the incorporation of pharmacophore of calcium channel blocker could improve the vasorelaxation activity of target compound. Xanthotoxol (4) also provided a good intermediate for the synthesis of (5i) (Scheme 2). Structures of all synthesized compounds were identified by 1 H-NMR and EI-MS.
RESULTS AND DISCUSSION

Vasorelaxation Activity
Vasodilatory activity of imperatorin derivatives was also evaluated. Vasodilatory activity was evaluated in mesenteric artery rings with endothelium pre-contracted with 3 µM phenylephrine (PE) [11] . Imperatorin was used as the positive control. All the tested compounds promoted relaxation in a dose-dependent manner and their maximal effects was observed at 100 µM. The vasodilatory activity of imperatorin derivatives was shown in Table 1 and Fig. ( 2).
Accroding to Table 1 and Fig. (2) , we found that compounds (5a), (5b), (5d) and (5e) exhibited stronger vasorelaxant activity (EC 50 = 1.02, 0.68, 0.59, 0.49 µM, respectively) than that of imperatorin (EC 50 = 1.12 µM). In general, all compounds showed excellent maximal relaxation comparable to that of imperatorin. Compound (5e), which has the better solubility than imperatorin, was identified as the most potent vasodilator activity (EC 50 = 0.49 µM). Comparing (5a) (EC 50 = 1.02 µM) and (5b) (EC 50 = 0.68 µM) with imperatorin, we found that the dimethyl group and olefinc bond in side chain was not essential for activity. Incorporation of morpholine ring reduced the vasodilator activity. For example, compound (5f) (EC 50 = 7.59 µM) exhibited much lower activity than other derivatives. The lesser vasorelaxant activity of (5g) (EC 50 = 1.48 µM) and (5h) (EC 50 = 2.95 µM) in comparison to (5c) (EC 50 = 1.15 µM) suggested that extending the length of the side chain was not favorable to activity. Incorporation of hydrophobic benzene ring to the nitrogen (5i) (EC 50 = 1.66 µM) displayed slightly weaker vasorelaxant activity than corresponding compound (5c) (EC 50 = 1.15 µM), which indicated that hydrophobic groups was not desirable for activity. Data are expressed as mean values ± S.E.M.
Prediction of ADME Properties by Volsurf
It is well known that a potential activity does not necessarily imply an acceptable bioavailability. Therefore, the molecular properties for adsorption, distribution, metabolism, and excretion (ADME) are crucial for drug design. The optimization of pharmacokinetic properties is still largely based on trial and error and constitutes a major bottleneck in lead compound optimization. The program VolSurf was used to correlate 3D molecular structures with physicochemical and pharmacokinetic properties. All compounds were filtered by Lipinski's rule of 5 [12] , and then submitted to Vol- Fig . (2) . Effects of imperatorin derivatives (5a, A), (5b, B), (5d, C) (5e, D) on relaxation in mesenteric artery rings compared with IMP (n=7).
surf in order to calculate predicted ADME properties such as Caco-2 permeability and blood-brain barrier (BBB) distribution [13] . The ADME properties of compounds were summarized in Table 2 including MW, LogP, number of H-bond acceptors and rotatable bonds, Caco-2 and BBB calculated values.
In Caco-2 permeation experiment, Volsurf was used to predict the behaviour of novel imperatorin derivatives. Most of them (5b-5i) exhibited low Caco-2 cell permeability. The polar surface areas of all the compounds were under 140 Å 2 , which suggested that all of them were orally available. The logBBB values of the most compounds were greater than 0.0 which indicated that the concentration of compounds in the brain was greater than concentration in blood. The method appears as a valuable new property filter in virtual screening and as a novel tool in optimizing the pharmacokinetic profile of pharmaceutically relevant imperatorin derivatives.
CONCLUSION
In summary, we have described the synthesis and evaluation of a novel series of imperatorin derivatives as vasorelaxant agents. In general, all the imperatorin derivatives showed perfect maximal relaxation comparable to that of imperatorin. Among the nine compounds, four of them, (5a), (5b), (5d) and (5e) have been characterized as agents with higher vasorelaxant effects on isolated rat mesenteric artery, although further studies are needed to determine the mechanisms underlying such activity. The most potent compound (5e) would be a promising structural template for the development of novel and more efficient vasorelaxant agents. The pharmacokinetic profile of all the imperatorin derivatives was predicted by means of Volsurf/SYBYL-X. Caco-2 cell permeability and blood-brain barrier permeation of the compounds were also predicted. Further studies on the mode of action and pharmacology of these compounds and structureactivity relationship around the core template will be reported in due course.
EXPERIMENTAL
Chemistry: General Procedures
All reactions except those in aqueous media were carried out by standard techniques for the exclusion of moisture. Solvents were purified before use according to standard procedures. All reactions were monitored by thin layer chromatography on 0.25-mm silica gel plates (60GF-254) and visualized with UV light. All melting points were determined on a Beijing micro-melting point apparatus and were uncorrected. 1 H-NMR spectra were recorded on a Bruker AVANCF 400 MHZ instrument in CDCl 3 solution with TMS as internal standard. Mass spectra were performed on a Shimadzu GC-MS-QP2010 instrument.
Preparation of Xanthoxol (4)
Xanthotoxia (3) (4.32 g, 20.00 mmol) was dissolved in anhydrous CH 2 Cl 2 (75 mL) and stirred under nitrogen atmosphere. Boron tribromide (6.88 mL in 73 mL CH 2 Cl 2 ) was added dropwise to the solution at 0 for 30 min. The mixture was then allowed to stir at room temperature for another 4 h. The reaction mixture was poured slowly into a stirred solution of saturated aqueous sodium bicarbonate (160 mL) and stirred for 1 h. The resulting colorless precipitate was recovered by filtration. The filtrate was neutralized with 2 M HCl to PH 7, to yield further product, which was also recovered by filtration. Both solids were combined and stirred in water (100 mL) for 1 h. Recovery by filtration and drying under vacuum yield xanthoxol (4) 
N-benzyl-2-chloro-N-methylethanamine hydrochloride (7) [14]
2-(benzyl(methyl)amino)ethanol (6) (4.88 mL, 30 mmol) was dissolved in anhydrous toluene (20 mL) and while stir- ring, so mixed with a solution of 2.84 mL (40 mmol) of thionyl chloride in 10 mL anhydrous toluene such that the temperature of the mixture remained between 25 and 30 . After boiling for a further 30 min, the hydrochloride was filtered and washed with ether to give 2.64 g (12 mmol, 40%) of N-benzyl-2-chloro-N-methylethanamine hydrochloride (7) as a white solid and used in subsequent steps without further purification.
Compounds (5a-5i) were obtained by etherification of compound (4) with halide in K 2 CO 3 /acetone or K 2 CO 3 /DMF according to the approach in Reference 16. 1.3. 9-(isopentyloxy)-7H-furo[3,2-g]chromen-7 -one (5a) [15] Anhydrous potassium carbonate (0.83 g, 6.0 mmol) was added to a solution of xanthoxol (4) (0.40 g, 2.0 mmol) in 20 mL acetone under an atmosphere of nitrogen. After stirring the suspension at room temperature for 30 min, (1-bromo-3-methylbutane (0.37 mL, 3.0 mmol) was added. The reaction mixture was stirred under reflux overnight (20 h) under nitrogen atmosphere. The mixture was filtered, and the filtrates were collected and concentrated in vacuo. The oil residue was purified by column chromatography (eluent petroleum ether/ethyl acetate=5:1) to give the product as a white solid (0.39 g, 72.2%). m.p.73-75 . 
5.
9-(allyloxy)-7H-furo[3,2-g]chromen-7-one (5b)
This compound was prepared as described above for (5a), starting from xanthoxol (4) (0.40 g, 2.0 mmol), anhydrous potassium carbonate (0.83 g, 6.0 mmol), and allyl bromide (0.25 mL, 3.0 mmol). The crude product was purified by column chromatography (eluent petroleum ether/ethyl acetate=3:1) to give a white solid. Yield: 93.0%, m.p. 80-81 . 
9-(2-(dimethylamino)ethoxy)-7H-furo[3,2-g]chromen-7-one (5c) [16]
Xanthoxol (4) (0.81 g, 4.0 mmol) was dissolved in anhydrous DMF (10 mL), and anhydrous potassium carbonate (2.21 g, 16.0 mmol) was added. Then 0.86 g (6.0 mmol) of 2-chloro-N,N-dimethylethanamine hydrochloride was added to the mixture. The reaction mixture was stirred at 90 for 25 h. The reaction was quenched by addition of ice water (50 mL) and extracted with trichloromethane (6×15 mL). The dried (Na 2 SO 4 ) organic layer was evaporated in vacuo and the residue was purified by column chromatography (eluent chloroform/methanol=10:1) to give a white solid (0.61 g, 2.20 mmol). Yield: 56.0%, m.p.77-78 . Compounds (5d-5h) were prepared by using the general procedure described above. (piperidin-1-yl) 
9-(2-
Pharmacological Evaluation
Vascular rings were prepared from the mesenteric artery of male Sprague-Dawley rats, and contraction studies were performed following the general procedure detailed in the literature [18] . After an equilibration period of 2 h, isometric contractions induced by PE (3 µM) were obtained. When contraction of the tissue in response to this vasoconstrictor agent had stabilized, cumulatively increasing concentrations of the tested compounds were added to the bath at 15-20 min intervals. Control tissues were simultaneously subjected to the same procedures, but omitting the compounds and adding the vehicle. The imperatorins-induced maximal relaxation (Emax) in mesenteric artery rings was calculated as a percentage of the contraction in response to PE (3 µM) [19] . All data were expressed as mean ± S.E.M. The half maximum effective concentration (EC 50 ) was defined as the concentration of the imperatorins that induced 50% of maximum relaxation from the contraction elicited by PE and was calculated from the concentration response curve by nonlinear regression (curve fit) using GraphPad Prism.
